George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,000 shares at $580.00 ($1.2M) on 2020-05-28, disclosed to the SEC on 2020-06-01.
Open-market sale of $1.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $578.00 | 500 | $289K | 24.6% |
| 2 | $580.00 | 500 | $290K | 24.7% |
| 3 | $595.00 | 500 | $298K | 25.3% |
| 4 | $598.02 | 500 | $299K | 25.4% |
| Total | $587.75 avg | 2,000 | $1.2M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |